[go: up one dir, main page]

MX2013003454A - Composiciones de vacuna mejoradas. - Google Patents

Composiciones de vacuna mejoradas.

Info

Publication number
MX2013003454A
MX2013003454A MX2013003454A MX2013003454A MX2013003454A MX 2013003454 A MX2013003454 A MX 2013003454A MX 2013003454 A MX2013003454 A MX 2013003454A MX 2013003454 A MX2013003454 A MX 2013003454A MX 2013003454 A MX2013003454 A MX 2013003454A
Authority
MX
Mexico
Prior art keywords
vaccine compositions
improved vaccine
compositions
improved
palsy
Prior art date
Application number
MX2013003454A
Other languages
English (en)
Inventor
Ulf Schroeder
Hans Arwidsson
Original Assignee
Eurocine Vaccines Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurocine Vaccines Ab filed Critical Eurocine Vaccines Ab
Publication of MX2013003454A publication Critical patent/MX2013003454A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a formulaciones de vacuna y adyuvantes para usarse, v.gr., en composiciones, evitando así el fenómeno de parálisis de Bell en una frecuencia por arriba de la ocurrencia natural.
MX2013003454A 2010-09-30 2011-09-30 Composiciones de vacuna mejoradas. MX2013003454A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201000887 2010-09-30
PCT/EP2011/067080 WO2012042003A1 (en) 2010-09-30 2011-09-30 Improved vaccine compositions

Publications (1)

Publication Number Publication Date
MX2013003454A true MX2013003454A (es) 2013-08-29

Family

ID=43608712

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013003454A MX2013003454A (es) 2010-09-30 2011-09-30 Composiciones de vacuna mejoradas.

Country Status (12)

Country Link
US (1) US20130243817A1 (es)
EP (1) EP2621524A1 (es)
JP (2) JP6296795B2 (es)
KR (1) KR101857839B1 (es)
CN (1) CN103298484B (es)
AU (1) AU2011310090B2 (es)
BR (1) BR112013007355A2 (es)
CA (1) CA2810597A1 (es)
MX (1) MX2013003454A (es)
NZ (1) NZ607792A (es)
RU (1) RU2592210C2 (es)
WO (1) WO2012042003A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2742952A1 (en) * 2012-12-17 2014-06-18 Eurocine Vaccines AB Influenza vaccine composition
JP2016502995A (ja) 2012-12-17 2016-02-01 ユーロシネ ヴァクシンズ アクチエボラーグ 鼻腔内予防接種投薬レジメン
KR102658198B1 (ko) * 2017-05-15 2024-04-16 얀센 백신스 앤드 프리벤션 비.브이. 안정한 바이러스 함유 조성물
WO2025073027A1 (pt) * 2023-10-02 2025-04-10 DOS SANTOS ROSA, Eduarda Disposição construtiva aplicada em equipamento de autosserviço para venda de vasilhames

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9602280D0 (sv) * 1996-06-10 1996-06-10 Pharmatrix Ab Immunstimulerande lipidformulering
US8410248B2 (en) * 1999-03-12 2013-04-02 Human Genome Sciences Inc. HWBAO62 polypeptides
US20050208602A1 (en) * 2001-08-10 2005-09-22 Rosen Craig A 89 human secreted proteins
AU2003301843A1 (en) * 2002-05-17 2004-06-07 Human Genome Sciences, Inc. 157 human secreted proteins
DK1567191T3 (da) * 2002-11-26 2011-01-03 Eurocine Vaccines Ab Ny amin-baseret adjuvans
CN103012304B (zh) * 2005-06-30 2014-07-23 卫材R&D管理有限公司 用于制备免疫佐剂的化合物
WO2007018152A1 (ja) * 2005-08-05 2007-02-15 The University Of Tokushima IgA抗体の選択的産生からIgA及びIgG両抗体産生への切換えを可能にする抗原薬物ビークルとこれを用いる経鼻・粘膜ワクチン
AU2009248810B2 (en) * 2008-05-23 2013-12-05 The Regents Of The University Of Michigan Nanoemulsion vaccines
CA2725381A1 (en) * 2008-05-23 2010-03-25 The Regents Of The University Of Michigan Nanoemulsion adjuvants
US20130178383A1 (en) * 2008-11-12 2013-07-11 David Spetzler Vesicle isolation methods
ES2618576T3 (es) * 2009-05-28 2017-06-21 Curna, Inc. Tratamiento de enfermedades relacionadas con un gen antivírico mediante la inhibición de una transcripción antisentido natural a un gen antivírico
EP2742952A1 (en) * 2012-12-17 2014-06-18 Eurocine Vaccines AB Influenza vaccine composition

Also Published As

Publication number Publication date
JP2016222704A (ja) 2016-12-28
CN103298484A (zh) 2013-09-11
NZ607792A (en) 2015-08-28
KR101857839B1 (ko) 2018-05-14
JP6296795B2 (ja) 2018-03-20
JP2013538841A (ja) 2013-10-17
US20130243817A1 (en) 2013-09-19
CA2810597A1 (en) 2012-04-05
CN103298484B (zh) 2017-04-26
EP2621524A1 (en) 2013-08-07
AU2011310090A1 (en) 2013-03-14
BR112013007355A2 (pt) 2016-07-12
RU2013120034A (ru) 2014-11-10
RU2592210C2 (ru) 2016-07-20
WO2012042003A1 (en) 2012-04-05
AU2011310090B2 (en) 2015-06-18
KR20130130711A (ko) 2013-12-02

Similar Documents

Publication Publication Date Title
MY186535A (en) Novel european prrsv strain
MX2011003473A (es) Composiciones para el cuidado bucal.
JOP20180102A1 (ar) مركب صيدلاني
MY152711A (en) Oral compositions containing a combination of natural extracts and related methods
IN2012DN02736A (es)
MX352324B (es) Vacunas multivalentes de nanovehiculos sinteticos.
PH12014501273A1 (en) Intranasal dexmedetomidine compositions and methods of use thereof
PL2437753T3 (pl) Syntetyczne adiuwanty glukopiranozylolipidowe oraz zawierające je kompozycje szczepionek
MX348823B (es) Formulaciones estables de linaclotida.
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MX2013002173A (es) Formas farmaceuticas dirigidas de epitopos multiples para la induccion de una respuesta inmunologica frente a antigenos.
MX352563B (es) Composiciones para el cuidado oral que contienen carbonato de calcio y silice.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
PH12013500554A1 (en) Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation
MX2013002175A (es) Formulaciones estables de antigenos rlp2086 de neisseria meningitidis.
PH12013500616A1 (en) Antibody compositions and methods of use
PH12015500611B1 (en) Oral care composition
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
IN2012DN03404A (es)
IN2014CN03454A (es)
MX2013003454A (es) Composiciones de vacuna mejoradas.
MX2015005112A (es) Composicion inmunogenica contra la aeromonas hydrophila.
PH12012502253A1 (en) Oral care compositions and methods
PH12015501147A1 (en) Synbiotic composition and use thereof
EP2501405A4 (en) COMPOSITION, METHOD, AND USES OF POX VIRUS ELEMENTS IN VACCINATE CONSTRUCTS